Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$266K Buy
4,822
+92
+2% +$4.99K 0.01% 211
2025
Q4
$232K Sell
4,730
-3,354
-41% -$156K 0.01% 211
2025
Q3
$349K Buy
8,084
+130
+2% +$5.08K 0.01% 210
2025
Q2
$305K Buy
7,954
+603
+8% +$23K 0.01% 213
2025
Q1
$285K Sell
7,351
-402
-5% -$14.7K 0.01% 216
2024
Q4
$262K Sell
7,753
-759
-9% -$27.3K 0.01% 230
2024
Q3
$348K Buy
8,512
+161
+2% +$6.59K 0.02% 220
2024
Q2
$321K Buy
+8,351
New +$351K 0.02% 212

Other funds holding GSK

Aviso Financial's GSK Position: Q1 2026 in Review

Aviso Financial increased its GSK (GSK) stake by 1.9% in Q1 2026, buying an estimated $4.99K and bringing the position to 4,822 shares worth $266K. The position accounts for 0.01% of the portfolio, ranked #211.

Aviso Financial first reported a position in GSK in Q2 2024 and has held it in 8 quarters since. The position peaked at $349K in Q3 2025. 1,032 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Aviso Financial held 4,822 shares of GSK worth $266K as of Q1 2026.
  • Aviso Financial bought 92 GSK shares in Q1 2026, an estimated $4.99K.
  • GSK made up 0.01% of Aviso Financial's portfolio in Q1 2026, its #211 holding.
  • Aviso Financial first reported a position in GSK in Q2 2024 and has held it in 8 quarters since.
  • Aviso Financial's GSK position peaked at $349K in Q3 2025.
  • 1,032 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Aviso Financial's 13F filing for Q1 2026, filed 14 May 2026.